Enterprise League logo
Hybrid Biotherapeutics Inc. Logo

Hybrid Biotherapeutics Inc.

Irvine, United States (US) · Health and Medical

Do your work at Hybrid Biotherapeutics Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

Hybrid Biotherapeutics Inc is an Irvine, California-based biotechnology company pioneering a novel myeloid cell therapy platform for cancer treatment.

We are developing Hybrid Neutrophils, a first-in-class autologous cell therapy that dramatically enhances the effectiveness of therapeutic antibodies in solid tumors.

Our platform centers on naturally occurring Hybrid (APC-like) Neutrophils, discovered at the University of Pennsylvania, which combine potent cytotoxicity with professional antigen presentation, directly killing tumor cells and activating adaptive immunity.

Hybrid Biotherapeutics is led by a multidisciplinary team of experts in immunology, cell therapy, and oncology, with a proven track record of advancing complex biologics. We are currently focused on EGFR-positive colorectal cancer (CRC) and EGFR-mutated non-small cell lung cancer (NSCLC), with broad expansion potential across antibody-addressable solid tumors.

Most teams do this before shortlisting


Contact Details

info@hybrid-bio.com

Irvine, United States (US), 5270 California Ave

Company Type

Private Limited Company

Employees

2-10

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after Hybrid Biotherapeutics Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.